Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Household Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study.
Komeda T, Takazono T, Hosogaya N, Ogura E, Fujiwara M, Miyauchi H, Ajisawa Y, Iwata S, Watanabe H, Honda K, Kitanishi Y, Hara K, Mukae H. Komeda T, et al. Among authors: hosogaya n. Clin Infect Dis. 2021 Jun 1;72(11):e859-e867. doi: 10.1093/cid/ciaa1622. Clin Infect Dis. 2021. PMID: 33103200
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Tashiro M, Izumikawa K, Minematsu A, Hirano K, Iwanaga N, Ide S, Mihara T, Hosogaya N, Takazono T, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Tashiro T, Kohno S. Tashiro M, et al. Among authors: hosogaya n. Antimicrob Agents Chemother. 2012 Jan;56(1):584-7. doi: 10.1128/AAC.05394-11. Epub 2011 Oct 24. Antimicrob Agents Chemother. 2012. PMID: 22024829 Free PMC article.
Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.
Tashiro M, Izumikawa K, Hirano K, Ide S, Mihara T, Hosogaya N, Takazono T, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Tashiro T, Kohno S. Tashiro M, et al. Among authors: hosogaya n. Antimicrob Agents Chemother. 2012 Sep;56(9):4870-5. doi: 10.1128/AAC.00514-12. Epub 2012 Jul 2. Antimicrob Agents Chemother. 2012. PMID: 22751542 Free PMC article.
Discrepancies in preferences regarding the care of terminal-phase pneumonia in elderly patients among patients, families, and doctors: A multicenter questionnaire survey in nagasaki, Japan.
Takazono T, Imamura Y, Kawakami K, Yamasaki N, Shimizu H, Usuki K, Kiyohara M, Hirayama T, Tashiro M, Hosogaya N, Saijo T, Yamamoto K, Miyazaki T, Yanagihara K, Izumikawa K, Mukae H. Takazono T, et al. Among authors: hosogaya n. Respir Investig. 2020 Nov;58(6):488-494. doi: 10.1016/j.resinv.2020.05.003. Epub 2020 Jul 3. Respir Investig. 2020. PMID: 32631765
Transition of triazole-resistant Aspergillus fumigatus isolates in a Japanese tertiary hospital and subsequent genetic analysis.
Takazono T, Ito Y, Tashiro M, Nakano Y, Hirayama T, Hosogaya N, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Kohno S, Mukae H, Izumikawa K. Takazono T, et al. Among authors: hosogaya n. J Infect Chemother. 2021 Mar;27(3):537-539. doi: 10.1016/j.jiac.2020.11.027. Epub 2020 Dec 10. J Infect Chemother. 2021. PMID: 33309631
Comparison of Hospitalization Incidence in Influenza Outpatients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study.
Komeda T, Takazono T, Hosogaya N, Miyazaki T, Ogura E, Iwata S, Miyauchi H, Honda K, Fujiwara M, Ajisawa Y, Watanabe H, Kitanishi Y, Hara K, Mukae H. Komeda T, et al. Among authors: hosogaya n. Clin Infect Dis. 2021 Sep 7;73(5):e1181-e1190. doi: 10.1093/cid/ciaa1870. Clin Infect Dis. 2021. PMID: 33354728 Free PMC article.
Reply to Shirata et al.
Komeda T, Takazono T, Hosogaya N, Ogura E, Miyauchi H, Iwata S, Mukae H. Komeda T, et al. Among authors: hosogaya n. Clin Infect Dis. 2021 Oct 5;73(7):e1766-e1767. doi: 10.1093/cid/ciaa1923. Clin Infect Dis. 2021. PMID: 33386407 No abstract available.
Evaluation of four commercial severe acute respiratory coronavirus 2 antibody tests.
Ashizawa N, Takazono T, Ohyama K, Nagasaki Y, Okamoto M, Hirayama T, Takahashi K, Yamanashi H, Tashiro M, Hosogaya N, Tanaka T, Yamamoto K, Fukuda Y, Imamura Y, Kawanami T, Miyazaki T, Sawai T, Fukushima K, Yatera K, Yanagihara K, Izumikawa K, Mukae H. Ashizawa N, et al. Among authors: hosogaya n. J Infect Chemother. 2021 Jul;27(7):1033-1038. doi: 10.1016/j.jiac.2021.03.008. Epub 2021 Mar 15. J Infect Chemother. 2021. PMID: 33781691 Free PMC article.
Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
Hosogaya N, Miyazaki T, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, Hori M, Kurokawa T, Kawasaki Y, Hanawa M, Fujii Y, Hanaoka H, Iwami S, Watashi K, Yamagoe S, Miyazaki Y, Wakita T, Izumikawa K, Yanagihara K, Mukae H, Kohno S; Nelfinavir Study Group. Hosogaya N, et al. Trials. 2021 Apr 28;22(1):309. doi: 10.1186/s13063-021-05282-w. Trials. 2021. PMID: 33910617 Free PMC article.
45 results